Cargando…
Mass cytometry staining for human bone marrow clinical samples
This protocol details a staining technique optimized for immunophenotyping of human bone marrow immune populations using mass cytometry. The protocol accounts for the limitations of working with human bone marrow, such as reduced viability, low cell counts, and fragile cell pellets, to successfully...
Autores principales: | Hallisey, Margaret, Dennis, Jenna, Abrecht, Charlotte, Pistofidis, Romanos Sklavenitis, Schork, Abigail N., Lightbody, Elizabeth D., Heilpern-Mallory, Daniel, Severgnini, Mariano, Ghobrial, Irene M., Hodi, F. Stephen, Baginska, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861824/ https://www.ncbi.nlm.nih.gov/pubmed/35243367 http://dx.doi.org/10.1016/j.xpro.2022.101163 |
Ejemplares similares
-
Simplified mass cytometry protocol for in-plate staining, barcoding, and cryopreservation of human PBMC samples in clinical trials
por: Abrecht, Charlotte, et al.
Publicado: (2022) -
Bone marrow niche in multiple myeloma and its precursor states
por: Sklavenitis-Pistofidis, Romanos, et al.
Publicado: (2019) -
Multiple Myeloma With Amplification of Chr1q: Therapeutic Opportunity and Challenges
por: Sklavenitis-Pistofidis, Romanos, et al.
Publicado: (2022) -
High-Throughput Mass Cytometry Staining for Immunophenotyping Clinical Samples
por: Thrash, Emily M., et al.
Publicado: (2020) -
Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors
por: Sklavenitis-Pistofidis, Romanos, et al.
Publicado: (2023)